Spots Global Cancer Trial Database for Efficacy of Kangliuwan for Recurrent Grade IV Glioma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy of Kangliuwan for Recurrent Grade IV Glioma
Official Title: Efficacy of Hospital Traditional Chinese Medicine Preparation Kangliuwan for Recurrent Grade IV Glioma: A Prospective Exploratory Clinical Study
Study ID: NCT03949192
Interventions
Study Description
Brief Summary: A Prospective Exploratory Clinical Study to explore the efficacy of Hospital Traditional Chinese Medicine Preparation Kangliuwan for Recurrent Grade IV Glioma.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Xuanwu Hospital, Beijing, Beijing, China
Contact Details
Name: Qingtang Lin, M.D., Ph.D.
Affiliation: Xuanwu Hospital, Beijing
Role: STUDY_CHAIR
Name: Xiaolan Lin, M.D.
Affiliation: Xuanwu Hospital, Beijing
Role: PRINCIPAL_INVESTIGATOR
Name: Ling Chen, M.D.
Affiliation: The General Hospital of People's Liberation Army (301 hospital)
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
